Mereo BioPharma Group plc Cash Flow Reinvestment Rate
Latest as of September 2023:
0.00x
Mereo BioPharma Group plc cash flow reinvestment rate. Mereo BioPharma Group plc (MAH0) has a Cash Flow Reinvestment Rate of 0.00x as of September 2023, reinvesting €0.00 (capex €0.00 ) from operating cash flow of €2.66 Million. Explore MAH0 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
€0.00
Capex + Investments
Operating Cash Flow
€2.66 Million
EUR
Capital Expenditures
€0.00
EUR
Mereo BioPharma Group plc Cash Flow Reinvestment Rate by Year (None–None)
Mereo BioPharma Group plc cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Mereo BioPharma Group plc. For the full cash flow conversion analysis, see Mereo BioPharma Group plc (MAH0) cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow